Analysen von Emmanuel Papadakis
| 03.07.18 | Roche overweight | Barclays Capital | |
| 25.06.18 | Roche overweight | Barclays Capital | |
| 11.06.18 | GSK kaufen | Barclays Capital | |
| 23.05.18 | Roche overweight | Barclays Capital | |
| 22.05.18 | AstraZeneca overweight | Barclays Capital | |
| 11.05.18 | Roche overweight | Barclays Capital | |
| 11.05.18 | AstraZeneca overweight | Barclays Capital | |
| 26.03.18 | GSK overweight | Barclays Capital | |
|
Werbung
|
|||
| 09.03.18 | Fresenius overweight | Barclays Capital | |
| 05.02.18 | Roche overweight | Barclays Capital | |
| 17.01.18 | GSK overweight | Barclays Capital | |
| 21.12.17 | Roche overweight | Barclays Capital | |
| 13.09.17 | Roche overweight | Barclays Capital | |
| 13.09.17 | AstraZeneca overweight | Barclays Capital | |
| 03.07.17 | AstraZeneca overweight | Barclays Capital | |
| 13.06.17 | Roche overweight | Barclays Capital | |
| 19.05.17 | Roche overweight | Barclays Capital | |
| 19.05.17 | Roche overweight | Barclays Capital | |
| 08.03.17 | Roche overweight | Barclays Capital | |
| 08.03.17 | AstraZeneca overweight | Barclays Capital | |